present in posttransplant biopsies from 1 alcohol user The purposes of this study were to determine among only. Alcohol use by alcoholics is uncommon in the first 5 a cohort of long-term alcoholic survivors after liver years after liver transplantation, and alcohol-associated transplantation (1) the incidence of alcohol use, (2) its liver injury is unusual. Mild nonspecific hepatitis is comeffect on allograft integrity and extrahepatic health, and mon in both alcohol users and nonusers alike. Orthotopic liver transplantation is an efficacious therapy center. Fifty alcoholic, long-term liver transplant recipi-for severe liver failure associated with alcoholism. Survival ents. The frequency of alcohol relapse, defined as any rates after liver transplantation are similar among alcoholics alcohol use in the period after transplantation, was de-and nonalcoholics.
tion of abstinence, or University of Michigan alcoholism
It remains uncertain whether alcohol use after liver transprognosis score. The median interval from transplanta-plantation has untoward consequences for allograft function. tion to alcohol relapse was 17 months, with a range of 3 Indeed, Bonet et al. have proposed that a relapse of alcohol to 45 months. Recurrent alcohol use was associated with abuse by alcoholics after liver transplantation may have parsignificant medical complications sufficient to require adoxical benefits, including reducing the incidence of acute admission to the hospital in 6 patients. One patient died cellular rejection. 10 The purposes of this study were (1) to of graft dysfunction, noncompliance with immunosup-document the incidence of alcohol use among a cohort of longpressant medications, and presumed graft rejection term alcoholic survivors after liver transplantation; (2) to while drinking. Mild or progressive hepatitis, which was determine the effect of alcohol use on allograft integrity and the most common abnormality in posttransplant liver extrahepatic health in these patients; and (3) in light of these biopsy findings, was equally distributed between both data, to review the pretransplant alcohol prognosis screening alcohol users and abstainers and sometimes occurred in process. the absence of antibody to hepatitis C virus antibodies. There was a similar frequency of biopsy-proven acute PATIENTS of liver transplantation in alcoholic liver disease. 2 All had undergone admissions for intoxication, pneumonia, delirium tremens, and a myocardial infarction in the first 4 years after trans-
RESULTS
plantation, during which time he refused psychiatric assistance. He then stopped drinking alcohol of his own volition, Clinical Features. Fifty-nine alcoholic patients received transplants during the period described. There were 9 early and he has remained abstinent for 26 months. In contrast, other patients within this cohort continue to consume alcohol deaths due to perioperative death (n Å 2), poor graft function, with or without sepsis (n Å 5), graft-vs.-host disease (n Å 1), on an intermittent or regular basis.
Histology. Forty-five explanted livers were reviewed. All and hepatoma (n Å 1). Three underwent a second transplantation. The median interval from transplantation to showed cirrhosis. None were accompanied by histological features of acute alcoholic hepatitis, combining a neutrophilic death in this subset was 33 days (range 1-150 days). On review of patients' case records, it was considered that they infiltrate, steatosis, Mallory bodies, necrosis of individual hepatocytes, and debris-filled phagocytes. In 14 explants, the did not reestablish their health and were consequently unable to exercise a choice regarding a return to drinking. They cirrhosis had the appearance of end-stage alcoholic injury including small nodules, loss of central zones, and steatosis. will not be considered further. Among the remaining cohort of 50 long-term survivors that forms the basis of the present The frequencies of histological alcoholic liver disease in the explanted livers were similar in the patients who subsereport, the median duration of follow-up was 63 months and was ¢4 years in 46 (92%). In this cohort, 33 recipients (66%) quently went on to alcoholic relapse and those who maintained sobriety after transplant (Table 2) . Thirty-one exreported no alcohol use throughout the duration of posttransplant follow-up and are termed alcoholic abstainers, whereas plants lacked etiologic markers, including patterns typical of alcoholic cirrhosis, and would be classified on histological 17 recipients (34%) were identified as having consumed alcohol at least once since the transplant and are termed alcohol grounds as cryptogenic. Evidence of other causes of liver injury such as a 1 -antitrypsin deficiency, primary biliary cirrhousers. Table 1 shows comparative clinical characteristics in these two subgroups. Abstainers and alcohol users were of sis, or hepatitis B viral infection was found in 9 explants, always in the patients who subsequently remained abstinent. similar age, sex distribution, and severity of liver dysfunction as shown by Child-Turcotte-Pugh classification at the time of All posttransplant biopsies have been reviewed in 33 subjects. Data in Table 2 represent the most abnormal biopsy the evaluation. 15 There were 4 alcohol abusers (classification 305) in each group, which was not statistically different. The in the biopsy series from each patient. Mild or progressive hepatitis was the most common abnormality and was equally median length of abstinence before evaluation was greater among abstainers than alcohol users, although this difference distributed between both alcohol users and abstainers. In all subjects, hepatitis C antibody testing after transplantation did not reach significance. Nine of 17 recipients who returned to alcohol use had pre-evaluation abstinence of less than 6 was available for review. Antibody to hepatitis C virus (anti-
AID Hepa 0068
/ 5p20$$1342 04-11-97 11:57:08 hpta WBS: Hepatology this is unlikely to be the only explantation, because the physiMild hepatitis 7 6 cians were aware of the drinking relapse in 13 of 19 cases.
Progressive hepatitis 6 2 Lack of a standardized selection process, and inclusion of only bining serial interview data with documentation at frequent clinic visits. We realize, however, that only prospective data gathering and aggressive case follow-up of the nonattenders would provide more definitive data. HCV) antibodies were present in approximately half of the It is clear from our observations that there is no characterpatients with histological hepatitis among both alcohol users istic pattern of posttransplant alcohol use. Indeed, although and abstainers (Table 3) . Anti-HCV antibodies were common we describe 17 alcoholic transplant recipients who returned also in the absence of histological hepatitis in both groups. to alcohol use, this group is made up of 17 individuals who There was a similar frequency of biopsy-proven acute cellular each behaved differently. We saw repeated pathological rejection in both users and abstainers. One patient, a post-drinking that continued throughout the observation period, transplant alcohol user, showed typical features of alcoholic profound pathological drinking followed by sustained abstiinjury on biopsy, including intense central zone steatosis and nence, a single episode of alcohol use leading to rehabilitation stellate perisinusoidal fibrosis.
and abstinence, and admitted minor alcohol use. The present report includes data from our previously published study
DISCUSSION
comparing drinking behavior in alcoholic and nonalcoholic liver transplant recipients. 16 This showed a similar prevaAlcoholic cirrhosis was the preoperative diagnosis in 2,499 liver transplants, or 15.6% of all transplantations performed lence of alcohol use after transplantation in both groups, but excessive use only occurred in the alcoholic recipients. Simiin the United States between 1988 and 1993. 20 The growth in the absolute number of liver transplants in alcoholic per-larly, Berlakovich et al. distinguished between ''harmful'' and other forms of drinking. 9 In the more general literature on sons has occurred against a background of an ongoing debate on both the practical and ethical implications of offering liver alcoholism, irrespective of liver transplantation, restoration of a controlled pattern of social alcohol use remains rare. 24 transplantation to persons with alcoholism. Previously when we and others have reported our experi-As yet, there are no data to support the contention that alcoholic liver transplant recipients can achieve a pattern of modence of liver transplantation in patients with end-stage alcoholic liver disease, we have concentrated on selection, early erate controlled alcohol use.
The data presented here show that whereas chronic hepatimortality, utilization of resources, or short-term recidivism. Table 4 summarizes these studies. They show clearly that tis is common, typical alcoholic injury to the grafted liver is not. In our series, no patient who was actively drinking mortality for alcoholics does not differ from that reported in nonalcoholic recipients. Table 4 also shows that alcoholic developed acute alcoholic hepatitis. Only 1 patient who was actively drinking developed alcoholic-type steatosis with exrelapse, however defined, is infrequent in the first 24 months after liver transplantation. The frequency of relapse in-tensive perisinusoidal fibrosis. The etiology of posttransplant hepatitis in our cohort is unclear. Many patients in both the creases as the duration of follow-up is extended. Berlakovich et al. reported on 44 long-term alcoholic survivors after liver user and abstinent groups are anti-HCV antibody positive.
These results are congruent with the frequent observation of transplantation and found that the frequency of relapse increased from 15% at 1 year to 31% at 3 years. 9 In the present anti-HCV and hepatitis C virus (HCV) RNA in the serum of alcoholic cirrhotics. 25, 26 However as shown in Table 3 , the study, we have found a similar incidence of reported alcohol use (34%), usually beginning more than 12 months after occurrence of hepatitis was poorly associated with anti-HCV. transplantation, among 50 alcoholics who were long-term liver transplant survivors. However, the present study also 
Abstainers Users
Alcohol use after transplantation, often labeled as recidivism, is defined inconsistently in various liver transplant ''recidivism'' because, lacking serial prospective measures, we Hepatitis, anti-HCV negative 7 3 feared that significant alcohol use would be missed if some anti-HCV negative, no hepatitis 6 5 degree of moderate or occasional drinking was excluded from AID Hepa 0068 / 5p20$$1342 04-11-97 11:57:08 hpta WBS: Hepatology We recognize that anti-HCV antibody measurements may be prine had been withdrawn. We have inferred that episodes of cellulitis and of pneumonia were alcohol related because inaccurate in patients receiving immunosuppressant medication. Consequently, the observation that posttransplant hep-they occurred during heavy drinking bouts, even though we recognize that cellulitis or pneumonia, or for that matter panatitis may be due to factors other than HCV would be strengthened by measures of HCV RNA in serum using poly-creatitis, can arise in liver transplant recipients without alcohol exposure. Despite the caveat that it is impossible to be merase chain reaction, which were not available in the present study. Even so, whereas HCV may account for some post-certain that alcohol use contributed to each of the extrahepatic phenomena described here, it is our impression that transplant hepatitis in alcoholic transplant recipients, it is unlikely to account for all. Previously, Hubscher has shown persistent alcohol abusers experience more medical problems than their abstinent counterparts and constitute a disproporthat nonprogressive low-grade hepatitis of uncertain etiology is common in long-term follow-up biopsies after liver trans-tionate burden on the posttransplant management team.
Therefore, it is our contention that the increased burden plantation. 27 Evidence is accumulating that HCV and alcohol act synergistically in producing liver damage. 25, 26 It is of in-of extrahepatic illness in relapsing alcoholic liver transplant recipients justifies pretransplant selection procedures that terest, therefore, that in the small sample of anti-HCV-positive patients in the alcohol-user group that liver injury was aim to identify those at greatest risk of posttransplant alcohol relapse. This viewpoint begs the question of whether we are not disproportionately severe.
In our study, alcohol use did not confer any immunosup-able to identify future drinkers. The determination of alcohol abuse or dependence did not distinguish future users from pressant benefit. Because 80% of acute cellular rejection occurs within the first 8 postoperative weeks, it is unlikely abstainers. In the present study, the prognosis for future abstinence was assessed in all recipients using the method that alcoholic relapse, which usually arises 12 months after transplantation, would play a significant immunity-modulat-we have described. 2, 4 This method includes a point system, which we have advocated as a tracking system rather than ing role. 28 Only once did we observe coincident alcohol relapse and a presumptive, i.e., not biopsy-proven, diagnosis of acute an absolute threshold. As shown in Table 1 , there were no differences in the prognosis scores calculated during precellular rejection, as a result of failure to maintain the prescribed immunosuppressive regimen. It appears uncommon transplant assessment among the subsequently abstinent and alcohol-using transplant recipients. We suspect that the that alcoholic patients are derelict with their medications, even when they are drinking. Indeed, we have previously prognosis scoring system is more valuable than it appears to be in these data, in part because the major screening process shown that the frequency of admitted failure to take prescribed immunosuppressive medications is similar for alco-for alcoholics to gain access to our liver transplant program occurs when the patient is referred by the primary care physiholic and nonalcoholic liver transplant recipients. 16 The present study is the first to demonstrate an impact of cian. In a review of 233 patients with alcohol abuse or dependence referred to our center for consideration for liver transalcohol use by alcoholic recipients on extrahepatic health. This arose from our clinical experience in which particular plantation, the Michigan Prognosis Score was 12 points or greater in 78.5%, suggesting that stable, insightful alcoholics patients developed clinical syndromes that seemed directly associated to pathological drinking. In some cases the associ-were most likely to be referred. 29 We therefore advocate maintaining a selection process that ation was incontrovertible, such as intoxication and delirium tremens. Other episodes, such as recurrent pancreatitis, were screens prospective alcoholic liver transplant candidates using a broad-based instrument such as the University of Michprobably alcohol associated given the patients acknowledged use of alcohol and the recurrence of pancreatitis after azathio-igan Alcoholism Prognosis Score rather than a time-based AID Hepa 0068 / 5p20$$1342 04-11-97 11:57:08 hpta WBS: Hepatology
